Entering text into the input field will update the search result below

COVID-19 Impact On Companion Animal Diagnostics Market: Rising Demand For Pet Insurance

Dec. 17, 2020 7:02 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

The growth in this market is driven by the rising companion animal population, increasing demand for pet insurance, and the growth in the number of veterinary practitioners in developed countries. The growing demand for rapid tests and portable instruments for point-of-care services is expected to offer potential growth opportunities for market players in the coming years.

What the Companion Animal Diagnostics Market Looks Like?

The companion animal diagnostics market is projected to reach USD 2.7 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 9.8%. Asia Pacific market to witness the highest growth during the forecast period.

Based on technology, the companion animal diagnostics market is segmented into clinical biochemistry, immunodiagnostics, hematology, urinalysis, molecular diagnostics, and other companion animal diagnostic technologies. The clinical biochemistry segment is expected to grow at the highest CAGR during the forecast period. The higher preference for various advanced clinical diagnostic products by veterinarians, pet owners, and laboratory technicians, and the wide applications of this technology are some of the major factors responsible for the large share of this segment.

Download PDF Brochure @ Companion Animal Diagnostics Market

On the basis of application, the companion animal diagnostics market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications. The clinical pathology segment is estimated to account for the largest share of the companion animal diagnostics market during the forecast period. The increasing demand for diagnostic products and consumables utilized during pathology testing and the growing volume of pathology tests performed for pets are the major factors that are expected to drive the growth of this segment in the coming years.

What Drives the Companion Animal Diagnostics Market?

The growth of the global market for Companion Animal Diagnostics is primarily influenced by the following factors:

  • Growth in the Companion Animal Population
  • Rising Demand for Pet Insurance
  • Growth in the Number of Veterinary Practitioners in Developed Economies

Geographical growth scenario of Companion Animal Diagnostics Market

The global companion animal diagnostics market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America is estimated to be the largest regional market for companion animal diagnostics. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period primarily due to the growing adoption of companion animals, increasing awareness about animal healthcare and zoonotic diseases, and the growing number of veterinary hospitals and clinics in several APAC countries.

Request for Sample Pages: Companion Animal Diagnostics Market

Leading market players and strategies adopted

IDEXX Laboratories, Inc. (US) and Zoetis, Inc. (US) are the major players operating in the companion animal diagnostics market. Some of the other players operating in this market are Thermo Fisher Scientific, Inc. (US), Virbac (France), Heska Corporation (US), Neogen Corporation (US), bioMérieux SA (France), IDvet (France), INDICAL Bioscience GmbH (Germany) [QIAGEN N.V. (Netherlands)], and Randox Laboratories Ltd. (UK).

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.